Questions for Eli Lilly

Buy Research paper [Order Now:]

Questions for Eli Lilly

As Bianca Sharma, which of the following three alternatives would you recommend to the Project Team Advisory Committee (PTAC) (see case Exhibit 10)? Why is there so much disagreement between experts on these options?

  • Take the lead migraine compound directly into clinicals and bring it to market as quickly as possible?
  • Spend more time to refine the current lead migraine compound [using combinatorial chemistry]?
  • Go back to basic research and spend significantly more time to search for a new migraine drug platform [using combinatorial chemistry]?

Note that Lilly’s management does not favor entering more than one compound into clinical trials because of cost and resource constraints (see case page 11).

Buy Research paper [Order Now:]

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: